Leo Simpson, MD

Dr. Leo Simpson is an Associate Professor at Baylor College of Medicine and is board-certified in Interventional Cardiology, Electrophysiology and Advanced Heart Failure and cardiac transplant.

Show full bio

Dr. Simpson earned his medical degree and completed his residency at the All India Institute of Medical Sciences. His extensive training included residency in Internal Medicine at Emory University followed by Cardiology and Interventional Cardiology fellowship at St. Luke’s Episcopal Hospital/Texas Heart Institute and then Cardiac Electrophysiology at Baylor University Medical Center in Dallas. He is affiliated with Texas Heart Institute at Baylor St. Luke’s Medical Center and an active member of the Heart Failure and Cardiac Transplantation team at the Texas Heart Institute.

Dr. Simpson is a member of the American Society of Echocardiography and the American Society of Nuclear Cardiology and is a Fellow of the American College of Cardiology, Fellow of the Heart Rhythm Society and Fellow of Society for Cardiovascular Angiography and Intervention.

He is an expert in the field of percutaneously inserted biventricular mechanical circulatory support (Impella, Tandem and ECMO), both for the treatment of refractory shock, ARDS and to support high risk percutaneous coronary revascularization, as well as Electrophysiological procedures. He also specializes in Percutaneous Patent Foramen Ovale (PFO) closure, Percutaneous Atrial septal Defect (ASD) closure, and MitraClip – a less-invasive treatment option for certain people with mitral regurgitation who are not suitable for surgery.

In addition to his clinical pursuits, his primary research interest is in the field of treatment of advanced heart failure. Dr. Simpson currently runs as a sub-investigator a randomized trial study – INOVATE-HF (INcrease OF VAgal TonE in chronic heart failure, a randomized study to establish Safety and Efficacy of CardioFit for treatment of subjects with heart failure and Left Ventricular Dysfunction) in this field. He is also the co-author of multiple publications involving left ventricular assist device and cardiomyopathy.

Dr. Simpson’s clinical and research interests include advanced heart failure, interventional cardiology, complex electrophysiological procedures, high risk percutaneous coronary revascularization, cardiogenic shock, peripheral interventions, Asd/vsd Septal closure, and ARDS

 

 

See Publications

Texas Heart Institute Positions

  • Teaching Staff, Cardiovascular Disease Fellowship
  • Teaching Staff, Interventional Cardiology Fellowship
  • Teaching Staff, Advanced Heart Failure and Transplant Cardiology Fellowship

Interests

  • Cardiovascular disease
  • Advanced heart failure
  • Interventional Cardiology
  • Electrophysiology
  • Cardiac transplantation
  • Mechanical Circulatory Support
  • Peripheral Interventions

Education

  • Undergraduate:

    All India Institute of Medical Sciences

  • Medical School:

    All India Institute of Medical Sciences

  • Residency:

    Emory University

  • Fellowships:

    Baylor College of Medicine
    Texas Heart Institute

Academic & Clinical Affiliations

Certifications

  • Interventional Cardiology, American Board of Internal Medicine
  • Electrophysiology, American Board of Internal Medicine
  • Heart Failure and Cardiac Transplantation, American Board of Internal Medicine

Honors, Awards and Memberships

  • Houstonia Magazine Top Doctor
  • CCU Fellow of the Year at Texas Heart Institute (2006)
  • 98th percentile for Internal Medicine Boards (2005)
  • Member of 3 Person Jeopardy team from Emory for the American College of Physicians, Georgia Chapter Annual Meeting (2004 0
  • J. Willis Hurst Resident Achievement Award: Best Intern of the Year 2002-2003, Emory University Hospital (2003)
  • Outstanding performance during first year of residency by House staff evaluation committee (2003)
  • Best Intern of the Month July 2002, Emory University
  • Catherine Sorrel prize Best Postgraduate in Pediatrics (2000)
  • Merit Certificate National Neonatal Ventilation
  • Fellow of American College of Cardiology (2012)
  • Fellow of Heart Rhythm Society (2012)
  • Fellow of Society of Cardiovascular Angiography and Intervention (2012)
  • The Texas Heart Institute Academic Professional Staff

Publications

4862227 AAQ89W3S 1 alternatives-to-animal-experimentation 10 date desc Simpson 2101 https://www.texasheart.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%2277U2UHFA%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gao%20et%20al.%22%2C%22parsedDate%22%3A%222023-04-29%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGao%2C%20F.%2C%20Kherallah%2C%20R.%2C%20Koetting%2C%20M.%20et%20al.%20%282023%29.%20Leadless%20pacemaker%20with%20transcatheter%20aortic%20valve%20implantation%3A%20A%20single-center%20experience.%20%26lt%3Bi%26gt%3BPacing%20Clin%20Electrophysiol%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fpace.14702%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fpace.14702%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Leadless%20pacemaker%20with%20transcatheter%20aortic%20valve%20implantation%3A%20A%20single-center%20experience%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Feng%22%2C%22lastName%22%3A%22Gao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Riyad%22%2C%22lastName%22%3A%22Kherallah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mackenzie%22%2C%22lastName%22%3A%22Koetting%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leo%22%2C%22lastName%22%3A%22Simpson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Seger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Srikanth%22%2C%22lastName%22%3A%22Koneru%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%22%2C%22lastName%22%3A%22Coselli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ourania%22%2C%22lastName%22%3A%22Preventza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vicente%22%2C%22lastName%22%3A%22Orozco-Sevilla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nastasya%22%2C%22lastName%22%3A%22Manon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guilherme%20V.%22%2C%22lastName%22%3A%22Silva%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20The%20safety%20and%20efficacy%20of%20leadless%20pacemakers%20%28LP%29%20in%20transcatheter%20aortic%20valve%20implant%20%28TAVI%29%20patients%20is%20not%20well%20known%20due%20to%20paucity%20of%20data.%20Herein%2C%20we%20compared%20outcomes%20between%20leadless%20pacemakers%20to%20traditional%20dual%20chamber%20pacemakers%20%28DCP%29%20following%20TAVI.%5CnMETHODS%3A%20A%20single-center%20retrospective%20study%20was%20conducted%2C%20including%20a%20total%20of%2027%20patients%20with%20LP%20and%2033%20patients%20with%20DCP%20after%20TAVI%20between%20November%202013%20and%20May%202021.%20We%20compared%20baseline%20demographics%2C%20pacemaker%20indications%2C%20complication%20rates%2C%20percent%20pacing%2C%20and%20ejection%20fractions.%5CnRESULTS%3A%20Leading%20indications%20for%20pacemaker%20implant%20were%20complete%20heart%20block%20%2874%25%20LP%2C%2073%25%20DCP%29%20and%20high%20degree%20atrioventricular%20block%20%2826%25%20LP%2C%2021%25%20DCP%29.%20Twenty-two%20%2882%25%29%20LP%20patients%20had%20devices%20implanted%20in%20the%20right%20ventricular%20septal-apex.%20Three%20%289%25%29%20DCP%20patients%20required%20rehospitalization%20for%20pocket%20related%20complications.%20Zero%20pacemaker-related%20mortality%20was%20observed%20in%20both%20groups.%20Frequency%20of%20ventricular%20pacing%20and%20ejection%20fraction%20was%20similar%20between%20LP%20and%20DCP%20groups.%5CnCONCLUSION%3A%20From%20this%20single-center%20retrospective%20study%2C%20LP%20implant%20was%20feasible%20following%20TAVI%20and%20was%20found%20to%20have%20comparable%20performance%20to%20DCPs.%20LPs%20may%20be%20a%20reasonable%20alternative%20in%20TAVI%20patients%20where%20single%20ventricular%20pacing%20is%20indicated.%20Larger%20studies%20are%20required%20to%20validate%20these%20findings.%22%2C%22date%22%3A%222023-04-29%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1111%5C%2Fpace.14702%22%2C%22ISSN%22%3A%221540-8159%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22SQD2CTYV%22%2C%22BJSZ96GT%22%2C%22DJYFUK6T%22%2C%22AAQ89W3S%22%2C%222K4N54U2%22%2C%22KRWEJ8EU%22%2C%22MZXU6P62%22%2C%22NTAHPDUG%22%2C%22FKNSPK49%22%5D%2C%22dateModified%22%3A%222023-07-21T18%3A44%3A29Z%22%7D%7D%2C%7B%22key%22%3A%22TL2AQYCP%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Akkanti%20et%20al.%22%2C%22parsedDate%22%3A%222022-09-23%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAkkanti%2C%20B.%2C%20Suarez%2C%20E.%20E.%2C%20O%26%23x2019%3BNeil%2C%20E.%20R.%20et%20al.%20%282022%29.%20Extracorporeal%20membrane%20oxygenation%20for%20COVID-19%3A%20Collaborative%20experience%20from%20the%20Texas%20Medical%20Center%20in%20Houston%20with%202%20years%20follow-up.%20%26lt%3Bi%26gt%3BASAIO%20J%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FMAT.0000000000001791%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FMAT.0000000000001791%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Extracorporeal%20membrane%20oxygenation%20for%20COVID-19%3A%20Collaborative%20experience%20from%20the%20Texas%20Medical%20Center%20in%20Houston%20with%202%20years%20follow-up%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bindu%22%2C%22lastName%22%3A%22Akkanti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erik%20E.%22%2C%22lastName%22%3A%22Suarez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erika%20R.%22%2C%22lastName%22%3A%22O%27Neil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aniket%20S.%22%2C%22lastName%22%3A%22Rali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rahat%22%2C%22lastName%22%3A%22Hussain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kha%22%2C%22lastName%22%3A%22Dinh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Divina%20M.%22%2C%22lastName%22%3A%22Tuazon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%20E.%22%2C%22lastName%22%3A%22MacGillivray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jose%20L.%22%2C%22lastName%22%3A%22Diaz-Gomez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leo%22%2C%22lastName%22%3A%22Simpson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joggy%20K.%22%2C%22lastName%22%3A%22George%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Biswajit%22%2C%22lastName%22%3A%22Kar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Patrick%20Herlihy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexis%20E.%22%2C%22lastName%22%3A%22Shafii%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Igor%20D.%22%2C%22lastName%22%3A%22Gregoric%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faisal%22%2C%22lastName%22%3A%22Masud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Subhasis%22%2C%22lastName%22%3A%22Chatterjee%22%7D%5D%2C%22abstractNote%22%3A%22Patients%20with%20severe%20refractory%20hypoxemic%20respiratory%20failure%20may%20benefit%20from%20extracorporeal%20membrane%20oxygenation%20%28ECMO%29%20for%20salvage%20therapy.%20The%20Coronavirus%20disease%202019%20%28COVID-19%29%20pandemic%20offered%20three%20high-volume%20independent%20ECMO%20programs%20at%20a%20large%20medical%20center%20the%20chance%20to%20collaborate%20to%20optimize%20ECMO%20care%20at%20the%20beginning%20of%20the%20pandemic%20in%20Spring%202020.%20Between%20March%2015%2C%202020%2C%20and%20May%2030%2C%202020%2C%203%2C615%20inpatients%20with%20COVID-19%20were%20treated%20at%20the%20Texas%20Medical%20Center.%20During%20this%20time%2C%2035%20COVID-19%20patients%20were%20cannulated%20for%20ECMO%2C%20all%20but%20one%20in%20a%20veno-venous%20configuration.%20At%20hospital%20discharge%2C%2023%20%2866%25%29%20of%20the%2035%20patients%20were%20alive.%20Twelve%20patients%20died%20of%20vasodilatory%20shock%20%28n%20%3D%209%29%2C%20intracranial%20hemorrhage%20%28n%20%3D%202%29%2C%20and%20cannulation-related%20bleeding%20and%20multiorgan%20dysfunction%20%28n%20%3D%201%29.%20The%20average%20duration%20of%20ECMO%20was%2013.6%20days%20in%20survivors%20and%2025.0%20days%20in%20nonsurvivors%20%28p%20%26lt%3B%200.04%29.%20At%201%20year%20follow-up%2C%20all%2023%20discharged%20patients%20were%20still%20alive%2C%20making%20the%201%20year%20survival%20rate%2066%25%20%2823%5C%2F35%29.%20At%202%20years%20follow-up%2C%20the%20overall%20rate%20of%20survival%20was%2063%25%20%2822%5C%2F35%29.%20Of%20those%20patients%20who%20survived%202%20years%2C%20all%20were%20at%20home%20and%20alive%20and%20well%20at%20follow-up.%22%2C%22date%22%3A%22Sept%2023%2C%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FMAT.0000000000001791%22%2C%22ISSN%22%3A%221538-943X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22AAQ89W3S%22%2C%22WS63FIXU%22%2C%22ZMAN8MMI%22%2C%22BQPL6CIB%22%2C%22VCK5HVUS%22%2C%22MDTREPAF%22%5D%2C%22dateModified%22%3A%222022-11-04T15%3A25%3A04Z%22%7D%7D%2C%7B%22key%22%3A%22KMJNS6GU%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Patel%20et%20al.%22%2C%22parsedDate%22%3A%222022-06%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BPatel%2C%20V.%2C%20Gray%2C%20Z.%2C%20Alam%2C%20M.%20et%20al.%20%282022%29.%20Peripheral%20extracorporeal%20membrane%20oxygenation%20support%20expands%20the%20application%20of%20robot-assisted%20coronary%20artery%20bypass.%20%26lt%3Bi%26gt%3BJTCVS%20Tech%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B13%26lt%3B%5C%2Fi%26gt%3B%2C%2092%26%23x2013%3B100.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.xjtc.2022.02.034%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.xjtc.2022.02.034%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Peripheral%20extracorporeal%20membrane%20oxygenation%20support%20expands%20the%20application%20of%20robot-assisted%20coronary%20artery%20bypass%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vivek%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zachary%22%2C%22lastName%22%3A%22Gray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mahboob%22%2C%22lastName%22%3A%22Alam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guilherme%20Vianna%22%2C%22lastName%22%3A%22Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leo%22%2C%22lastName%22%3A%22Simpson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kenneth%22%2C%22lastName%22%3A%22Liao%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20Robot-assisted%20coronary%20artery%20bypass%20%28RCAB%29%20is%20typically%20not%20offered%20to%20higher%20risk%20patients%20with%20reduced%20cardiopulmonary%20function%2C%20critical%20coronary%20artery%20disease%2C%20and%20challenging%20chest%20wall%20anatomy.%20In%20this%20study%2C%20we%20report%20the%20novel%20use%20of%20nonemergency%20intraoperative%20peripheral%20extracorporeal%20membrane%20oxygenation%20as%20partial%20cardiopulmonary%20support%20during%20RCAB%20for%20patients%20who%20were%20considered%20high-risk%20candidates%20for%20conventional%20CAB%20and%20at%20the%20same%20time%20not%20eligible%20for%20RCAB%20without%20cardiopulmonary%20support.%5CnMETHODS%3A%20Forty-five%20high%20risk%20patients%20%28mean%20age%2C%2068%5Cu00a0years%3B%20Society%20of%20Thoracic%20Surgeons%20score%2C%206.27%25%3B%20ejection%20fraction%2C%2045%25%29%20underwent%20RCAB%20with%20nonemergency%20peripheral%20extracorporeal%20membrane%20oxygenation%20support%20for%20the%20following%20indications%3A%20inability%20to%20tolerate%20single-lung%20ventilation%20%28n%5Cu00a0%3D%5Cu00a017%3B%2038%25%29%2C%20low%20ejection%20fraction%20%26lt%3B35%25%20%28n%5Cu00a0%3D%5Cu00a017%3B%2038%25%29%2C%20inadequate%20exposure%20of%20internal%20thoracic%20artery%20%28n%5Cu00a0%3D%5Cu00a024%3B%2053%25%29%2C%20critical%20coronary%20artery%20disease%20%28n%5Cu00a0%3D%5Cu00a016%3B%2036%25%29%2C%20and%20hemodynamic%20instability%20after%20anesthesia%20induction%20%28n%5Cu00a0%3D%5Cu00a03%3B%207%25%29.%20Following%20robotic%20internal%20thoracic%20artery%20takedown%2C%20all%20patients%20had%20beating%20heart%20minimally%20invasive%20direct%20CAB%20through%20a%202-inch%20minithoracotomy.%5CnRESULTS%3A%20Up%20to%2030%5Cu00a0days%2C%20there%20were%20no%20strokes%20%280%25%29%2C%20myocardial%20infarctions%20%280%25%29%2C%20or%20access%20vessel%20complications%20%280%25%29.%20One%20noncardiac%20related%20mortality%20%282.2%25%29%20was%20related%20to%20hemodialysis%20access%20issues%20in%20a%20patient%20with%20preexisting%20end-stage%20renal%20disease.%20One%20redo-CAB%20%282.2%25%29%20patient%20required%20sternotomy%20to%20locate%20the%20target%20vessel.%20Thirty-four%20%2875.6%25%29%20patients%20were%20extubated%20within%206%5Cu00a0hours%20of%20surgery.%5CnCONCLUSIONS%3A%20Our%20results%20examine%20the%20feasibility%20of%20using%20peripheral%20extracorporeal%20membrane%20oxygenation%20during%20RCAB%20for%20high-risk%20patients%20who%20otherwise%20had%20limited%20options.%20The%20use%20of%20peripheral%20extracorporeal%20membrane%20oxygenation%20in%20RCAB%20can%20potentially%20expand%20the%20surgical%20treatment%20options%20in%20high-risk%20coronary%20artery%20disease%20patients.%22%2C%22date%22%3A%22Jun%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.xjtc.2022.02.034%22%2C%22ISSN%22%3A%222666-2507%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22ZL4RPFGU%22%2C%22AAQ89W3S%22%2C%222K4N54U2%22%2C%22C2VFJYPK%22%2C%22UWTRFEPH%22%2C%22FA6KSIY7%22%5D%2C%22dateModified%22%3A%222023-02-14T20%3A19%3A19Z%22%7D%7D%2C%7B%22key%22%3A%22TQTFA93M%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Shah%20et%20al.%22%2C%22parsedDate%22%3A%222022-01-31%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BShah%2C%20S.%20J.%2C%20Borlaug%2C%20B.%20A.%2C%20Chung%2C%20E.%20S.%20et%20al.%20%282022%29.%20Atrial%20shunt%20device%20for%20heart%20failure%20with%20preserved%20and%20mildly%20reduced%20ejection%20fraction%20%28REDUCE%20LAP-HF%20II%29%3A%20a%20randomised%2C%20multicentre%2C%20blinded%2C%20sham-controlled%20trial.%20%26lt%3Bi%26gt%3BLancet%26lt%3B%5C%2Fi%26gt%3B%2C%20S0140-6736%2822%2900016%26%23x2013%3B2.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS0140-6736%2822%2900016-2%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS0140-6736%2822%2900016-2%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Atrial%20shunt%20device%20for%20heart%20failure%20with%20preserved%20and%20mildly%20reduced%20ejection%20fraction%20%28REDUCE%20LAP-HF%20II%29%3A%20a%20randomised%2C%20multicentre%2C%20blinded%2C%20sham-controlled%20trial%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sanjiv%20J.%22%2C%22lastName%22%3A%22Shah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Barry%20A.%22%2C%22lastName%22%3A%22Borlaug%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eugene%20S.%22%2C%22lastName%22%3A%22Chung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Donald%20E.%22%2C%22lastName%22%3A%22Cutlip%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philippe%22%2C%22lastName%22%3A%22Debonnaire%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20S.%22%2C%22lastName%22%3A%22Fail%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qi%22%2C%22lastName%22%3A%22Gao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gerd%22%2C%22lastName%22%3A%22Hasenfu%5Cu00df%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rami%22%2C%22lastName%22%3A%22Kahwash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20M.%22%2C%22lastName%22%3A%22Kaye%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sheldon%20E.%22%2C%22lastName%22%3A%22Litwin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philipp%22%2C%22lastName%22%3A%22Lurz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20M.%22%2C%22lastName%22%3A%22Massaro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rajeev%20C.%22%2C%22lastName%22%3A%22Mohan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20J.%22%2C%22lastName%22%3A%22Ricciardi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Scott%20D.%22%2C%22lastName%22%3A%22Solomon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aaron%20L.%22%2C%22lastName%22%3A%22Sverdlov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vijendra%22%2C%22lastName%22%3A%22Swarup%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dirk%20J.%22%2C%22lastName%22%3A%22van%20Veldhuisen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sebastian%22%2C%22lastName%22%3A%22Winkler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%20B.%22%2C%22lastName%22%3A%22Leon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22REDUCE%20LAP-HF%20II%20investigators%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Placement%20of%20an%20interatrial%20shunt%20device%20reduces%20pulmonary%20capillary%20wedge%20pressure%20during%20exercise%20in%20patients%20with%20heart%20failure%20and%20preserved%20or%20mildly%20reduced%20ejection%20fraction.%20We%20aimed%20to%20investigate%20whether%20an%20interatrial%20shunt%20can%20reduce%20heart%20failure%20events%20or%20improve%20health%20status%20in%20these%20patients.%5CnMETHODS%3A%20In%20this%20randomised%2C%20international%2C%20blinded%2C%20sham-controlled%20trial%20performed%20at%2089%20health-care%20centres%2C%20we%20included%20patients%20%28aged%20%5Cu226540%20years%29%20with%20symptomatic%20heart%20failure%2C%20an%20ejection%20fraction%20of%20at%20least%2040%25%2C%20and%20pulmonary%20capillary%20wedge%20pressure%20during%20exercise%20of%20at%20least%2025%20mm%20Hg%20while%20exceeding%20right%20atrial%20pressure%20by%20at%20least%205%20mm%20Hg.%20Patients%20were%20randomly%20assigned%20%281%3A1%29%20to%20receive%20either%20a%20shunt%20device%20or%20sham%20procedure.%20Patients%20and%20outcome%20assessors%20were%20masked%20to%20randomisation.%20The%20primary%20endpoint%20was%20a%20hierarchical%20composite%20of%20cardiovascular%20death%20or%20non-fatal%20ischemic%20stroke%20at%2012%20months%2C%20rate%20of%20total%20heart%20failure%20events%20up%20to%2024%20months%2C%20and%20change%20in%20Kansas%20City%20Cardiomyopathy%20Questionnaire%20overall%20summary%20score%20at%2012%20months.%20Pre-specified%20subgroup%20analyses%20were%20conducted%20for%20the%20heart%20failure%20event%20endpoint.%20Analysis%20of%20the%20primary%20endpoint%2C%20all%20other%20efficacy%20endpoints%2C%20and%20safety%20endpoints%20was%20conducted%20in%20the%20modified%20intention-to-treat%20population%2C%20defined%20as%20all%20patients%20randomly%20allocated%20to%20receive%20treatment%2C%20excluding%20those%20found%20to%20be%20ineligible%20after%20randomisation%20and%20therefore%20not%20treated.%20This%20study%20is%20registered%20with%20ClinicalTrials.gov%2C%20NCT03088033.%5CnFINDINGS%3A%20Between%20May%2025%2C%202017%2C%20and%20July%2024%2C%202020%2C%201072%20participants%20were%20enrolled%2C%20of%20whom%20626%20were%20randomly%20assigned%20to%20either%20the%20atrial%20shunt%20device%20%28n%3D314%29%20or%20sham%20procedure%20%28n%3D312%29.%20There%20were%20no%20differences%20between%20groups%20in%20the%20primary%20composite%20endpoint%20%28win%20ratio%201%5Cu00b70%20%5B95%25%20CI%200%5Cu00b78-1%5Cu00b72%5D%3B%20p%3D0%5Cu00b785%29%20or%20in%20the%20individual%20components%20of%20the%20primary%20endpoint.%20The%20prespecified%20subgroups%20demonstrating%20a%20differential%20effect%20of%20atrial%20shunt%20device%20treatment%20on%20heart%20failure%20events%20were%20pulmonary%20artery%20systolic%20pressure%20at%2020W%20of%20exercise%20%28pinteraction%3D0%5Cu00b7002%20%5B%26gt%3B70%20mm%20Hg%20associated%20with%20worse%20outcomes%5D%29%2C%20right%20atrial%20volume%20index%20%28pinteraction%3D0%5Cu00b7012%20%5B%5Cu226529%5Cu00b77%20mL%5C%2Fm2%2C%20worse%20outcomes%5D%29%2C%20and%20sex%20%28pinteraction%3D0%5Cu00b702%20%5Bmen%2C%20worse%20outcomes%5D%29.%20There%20were%20no%20differences%20in%20the%20composite%20safety%20endpoint%20between%20the%20two%20groups%20%28n%3D116%20%5B38%25%5D%20for%20shunt%20device%20vs%20n%3D97%20%5B31%25%5D%20for%20sham%20procedure%3B%20p%3D0%5Cu00b711%29.%5CnINTERPRETATION%3A%20Placement%20of%20an%20atrial%20shunt%20device%20did%20not%20reduce%20the%20total%20rate%20of%20heart%20failure%20events%20or%20improve%20health%20status%20in%20the%20overall%20population%20of%20patients%20with%20heart%20failure%20and%20ejection%20fraction%20of%20greater%20than%20or%20equal%20to%2040%25.%5CnFUNDING%3A%20Corvia%20Medical.%22%2C%22date%22%3A%22Jan%2031%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2FS0140-6736%2822%2900016-2%22%2C%22ISSN%22%3A%221474-547X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%229FBUJBMU%22%2C%22AAQ89W3S%22%2C%222K4N54U2%22%2C%22S7WF6DG3%22%2C%22WC4XX237%22%5D%2C%22dateModified%22%3A%222022-02-25T20%3A26%3A12Z%22%7D%7D%2C%7B%22key%22%3A%22QY6BEY4P%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lamba%20et%20al.%22%2C%22parsedDate%22%3A%222021-12-30%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLamba%2C%20H.%20K.%2C%20Musfee%2C%20F.%20I.%2C%20Chatterjee%2C%20S.%20et%20al.%20%282021%29.%20The%20influence%20of%20preoperative%20dialysis%20on%20survival%20after%20continuous-flow%20left%20ventricular%20assist%20device%20implantation.%20%26lt%3Bi%26gt%3BInteract%20Cardiovasc%20Thorac%20Surg%26lt%3B%5C%2Fi%26gt%3B%2C%20ivab357.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Ficvts%5C%2Fivab357%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Ficvts%5C%2Fivab357%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20influence%20of%20preoperative%20dialysis%20on%20survival%20after%20continuous-flow%20left%20ventricular%20assist%20device%20implantation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harveen%20K.%22%2C%22lastName%22%3A%22Lamba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fadi%20I.%22%2C%22lastName%22%3A%22Musfee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Subhasis%22%2C%22lastName%22%3A%22Chatterjee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajith%20P.%22%2C%22lastName%22%3A%22Nair%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20B.%22%2C%22lastName%22%3A%22Civitello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leo%22%2C%22lastName%22%3A%22Simpson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.%20H.%22%2C%22lastName%22%3A%22Frazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%20V.%22%2C%22lastName%22%3A%22Letsou%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVES%3A%20Dialysis%20is%20considered%20a%20contraindication%20to%20continuous-flow%20left%20ventricular%20assist%20device%20%28CF-LVAD%29%20implantation.%20We%20evaluated%20clinical%20outcomes%20and%20survival%20in%20carefully%20selected%2C%20low-risk%20patients%20with%20renal%20failure%20who%20required%20dialysis%20before%20CF-LVAD%20implantation.%5CnMETHODS%3A%20We%20extracted%20medical%20record%20data%20of%20patients%20who%20underwent%20CF-LVAD%20placement%20at%20our%20centre%20between%201%20January%202006%20and%2031%20August%202017%2C%20with%202%20clinical%20scenarios%3A%20those%20who%20required%20long-term%20%28%26gt%3B14%20days%29%20dialysis%20and%20those%20who%20required%20short-term%20%28%5Cu226414%20days%29%20dialysis%20immediately%20before%20implantation.%20Demographic%2C%20clinical%20and%20intraoperative%20characteristics%20and%20survival%20outcomes%20were%20assessed.%5CnRESULTS%3A%20Of%20621%20patients%20who%20underwent%20CF-LVAD%20implantation%20during%20the%20study%20period%2C%2031%20underwent%20dialysis%20beforehand.%20Of%20these%2C%2017%20required%20long-term%20dialysis%20%2813%20haemodialysis%2C%204%20peritoneal%20dialysis%29%2C%20and%2014%20underwent%20short-term%20haemodialysis.%20Compared%20with%20the%20long-term%20dialysis%20patients%2C%20the%20short-term%20dialysis%20patients%20were%20more%20likely%20to%20be%20Interagency%20Registry%20for%20Mechanically%20Assisted%20Circulatory%20Support%20profile%201-2%20%2892.9%25%20vs%2070.6%25%3B%20P%20%26lt%3B%200.001%29%2C%20to%20have%20needed%20preoperative%20mechanical%20circulatory%20support%20%2878.6%25%20vs%2070.6%25%3B%20P%20%26lt%3B%200.01%29%20and%20to%20have%20higher%20in-hospital%20mortality%20%2885.7%25%20vs%2029.4%25%3B%20P%20%3D%200.01%29.%20Patients%20stable%20on%20long-term%20dialysis%20had%20acceptable%20overall%20survival%20and%20markedly%20better%206-month%20and%201-year%20survival%20than%20those%20with%20short-term%20dialysis%20before%20implantation%20%2864.7%25%20vs%2014.3%25%20and%2058.8%25%20vs%207.1%25%2C%20respectively%3B%20P%20%26lt%3B%200.001%29.%5CnCONCLUSIONS%3A%20Carefully%20selected%20patients%20who%20are%20stable%20on%20long-term%20dialysis%20have%20acceptable%20survival%20rates%20after%20CF-LVAD%20implantation.%20Patients%20with%20acute%20renal%20failure%20had%20much%20poorer%20outcomes%20than%20those%20with%20chronic%20end-stage%20renal%20disease.%22%2C%22date%22%3A%22Dec%2030%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Ficvts%5C%2Fivab357%22%2C%22ISSN%22%3A%221569-9285%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22SE7HDD49%22%2C%229FBUJBMU%22%2C%22YZAQAZIS%22%2C%22AAQ89W3S%22%2C%22S7WF6DG3%22%2C%22VCK5HVUS%22%2C%22AUPQENLZ%22%5D%2C%22dateModified%22%3A%222022-01-07T20%3A37%3A36Z%22%7D%7D%2C%7B%22key%22%3A%22RZHSHNHU%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chen%20et%20al.%22%2C%22parsedDate%22%3A%222021-10%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BChen%2C%20Q.%2C%20Pollet%2C%20M.%2C%20Mehta%2C%20A.%20et%20al.%20%282021%29.%20Delayed%20removal%20of%20a%20percutaneous%20left%20ventricular%20assist%20device%20for%20patients%20undergoing%20catheter%20ablation%20of%20ventricular%20tachycardia%20is%20associated%20with%20increased%2090-day%20mortality.%20%26lt%3Bi%26gt%3BJ%20Interv%20Card%20Electrophysiol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B62%26lt%3B%5C%2Fi%26gt%3B%2C%2049%26%23x2013%3B56.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs10840-020-00875-y%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs10840-020-00875-y%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Delayed%20removal%20of%20a%20percutaneous%20left%20ventricular%20assist%20device%20for%20patients%20undergoing%20catheter%20ablation%20of%20ventricular%20tachycardia%20is%20associated%20with%20increased%2090-day%20mortality%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qi%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%22%2C%22lastName%22%3A%22Pollet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adwait%22%2C%22lastName%22%3A%22Mehta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shuyu%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juliette%22%2C%22lastName%22%3A%22Dean%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%22%2C%22lastName%22%3A%22Parenti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francia%22%2C%22lastName%22%3A%22Rojas-Delgado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leo%22%2C%22lastName%22%3A%22Simpson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jie%22%2C%22lastName%22%3A%22Cheng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nilesh%22%2C%22lastName%22%3A%22Mathuria%22%7D%5D%2C%22abstractNote%22%3A%22PURPOSE%3A%20Assess%20if%20timing%20of%20removal%20of%20a%20percutaneous%20left%20ventricular%20assist%20device%20%28pLVAD%29%20after%20ventricular%20tachycardia%20%28VT%29%20ablation%20alters%20patient%20outcomes.%5CnMETHODS%3A%20Sixty-nine%20patients%20underwent%20pLVAD%20support.%20Patients%20were%20divided%20into%20early%20%28%26lt%3B%5Cu200924%5Cu00a0h%2C%20n%5Cu00a0%3D%5Cu200943%29%20and%20delayed%20%28%5Cu2265%5Cu200924%5Cu00a0h%2C%20n%5Cu00a0%3D%5Cu200926%29%20removal%20groups%20after%20ablation.%20Factors%20for%20delayed%20pLVAD%20removal%20and%20predictors%20of%2090-day%20mortality%20were%20analyzed.%5CnRESULTS%3A%20The%20delayed%20removal%20group%20had%20lower%20LVEF%20%2827.1%5Cu2009%5Cu00b1%5Cu20099.3%25%20vs.%2020.6%5Cu2009%5Cu00b1%5Cu20095.4%25%2C%20p%5Cu2009%3D%5Cu20090.002%29%2C%20greater%20percentage%20LVEF%20%26lt%3B%5Cu200925%25%20%2858.1%25%20vs.%2084.6%25%2C%20p%5Cu2009%3D%5Cu20090.02%29%2C%20and%20more%20VT%20storm%20%2841.9%25%20vs.%2096.2%25%2C%20p%5Cu2009%26lt%3B%5Cu20090.001%29.%20Ventricular%20fibrillation%20%28VF%29%20was%20induced%20in%209%5C%2F69%20%2813%25%29%2C%20with%20incidence%20higher%20in%20delayed%20removal%20group%20%2827%25%20vs.%205%25%2C%20p%5Cu2009%3D%5Cu20090.002%29.%20VT%20storm%20%28OR%5Cu2009%3D%5Cu200934.72%2C%2095%25%20CI%2C%204.30-280.33%3B%20p%5Cu2009%3D%5Cu20090.001%29%2C%20LVEF%20%26lt%3B%5Cu200925%25%20%28OR%5Cu2009%3D%5Cu20093.95%2C%2095%25%20CI%2C%201.16-13.48%3B%20p%5Cu2009%3D%5Cu20090.03%29%2C%20and%20VF%20induced%20during%20ablation%20%28OR%5Cu2009%3D%5Cu20099.25%2C%2095%25%20CI%2C%201.71-50.0%3B%20p%5Cu2009%3D%5Cu20090.01%29%20were%20associated%20with%20delayed%20pLVAD%20removal%20in%20univariate%20analysis.%20Delayed%20pLVAD%20removal%20had%20a%20significantly%20higher%2090-day%20mortality%20rate%20%282.3%25%20vs%2030.2%25%3B%20p%5Cu2009%26lt%3B%5Cu20090.001%29.%20Univariate%20Cox%20proportional%20hazard%20regression%20analysis%20revealed%20delayed%20pLVAD%20removal%20was%20a%20significant%20predictor%20of%2090-day%20mortality.%5CnCONCLUSIONS%3A%20Prolonged%20pLVAD%20insertion%20%28%5Cu2265%5Cu00a024%5Cu00a0h%29%20after%20VT%20ablation%20was%20associated%20with%20VT%20storm%2C%20LVEF%20%26lt%3B%5Cu200925%25%2C%20and%20VF%20induced%20during%20ablation.%20Delayed%20pLVAD%20removal%20was%20a%20significant%20predictor%20of%2090-day%20mortality%20in%20patients%20undergoing%20VT%20ablation.%22%2C%22date%22%3A%22Oct%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs10840-020-00875-y%22%2C%22ISSN%22%3A%221572-8595%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%228EPJLFD3%22%2C%22AAQ89W3S%22%2C%22CEPAWXUI%22%2C%22B2JSS4XR%22%2C%22R4DG8MRF%22%2C%226CLB47ZH%22%5D%2C%22dateModified%22%3A%222021-10-07T17%3A45%3A54Z%22%7D%7D%2C%7B%22key%22%3A%223SXXRRI8%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kherallah%20et%20al.%22%2C%22parsedDate%22%3A%222021-04-15%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKherallah%2C%20R.%20Y.%2C%20Harrison%2C%20D.%2C%20Preventza%2C%20O.%20et%20al.%20%282021%29.%20Transcatheter%20aortic%20valve%20replacement%20after%20chest%20radiation%3A%20A%20propensity-matched%20analysis.%20%26lt%3Bi%26gt%3BInt%20J%20Cardiol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B329%26lt%3B%5C%2Fi%26gt%3B%2C%2050%26%23x2013%3B55.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ijcard.2020.12.054%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ijcard.2020.12.054%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Transcatheter%20aortic%20valve%20replacement%20after%20chest%20radiation%3A%20A%20propensity-matched%20analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Riyad%20Y.%22%2C%22lastName%22%3A%22Kherallah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Darren%22%2C%22lastName%22%3A%22Harrison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ourania%22%2C%22lastName%22%3A%22Preventza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guilherme%20V.%22%2C%22lastName%22%3A%22Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%20G.%22%2C%22lastName%22%3A%22Dougherty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephanie%20A.%22%2C%22lastName%22%3A%22Coulter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leo%22%2C%22lastName%22%3A%22Simpson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neil%20E.%22%2C%22lastName%22%3A%22Strickman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ali%22%2C%22lastName%22%3A%22Mortazavi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Palaskas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20D.%22%2C%22lastName%22%3A%22Fish%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zvonimir%22%2C%22lastName%22%3A%22Krajcer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raymond%20F.%22%2C%22lastName%22%3A%22Stainback%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20Carlos%20Plana%22%2C%22lastName%22%3A%22Gomez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20J.%22%2C%22lastName%22%3A%22Livesay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20S.%22%2C%22lastName%22%3A%22Coselli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Srikanth%22%2C%22lastName%22%3A%22Koneru%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Chest%20radiation%20therapy%20%28CRT%29%20for%20malignant%20thoracic%20neoplasms%20is%20associated%20with%20development%20of%20valvular%20heart%20disease%20years%20later.%20As%20previous%20radiation%20exposure%20can%20complicate%20surgical%20treatment%2C%20transcatheter%20aortic%20valve%20replacement%20%28TAVR%29%20has%20emerged%20as%20an%20alternative.%20However%2C%20outcomes%20data%20are%20lacking%20for%20TAVR%20patients%20with%20a%20history%20of%20CRT.%5CnMETHODS%3A%20We%20conducted%20a%20retrospective%20study%20of%20all%20patients%20who%20underwent%20a%20TAVR%20procedure%20at%20a%20single%20institution%20between%20September%202012%20and%20November%202018.%20Among%201341%20total%20patients%2C%2050%20had%20previous%20CRT.%20These%20were%20propensity-matched%20in%20a%201%3A2%20ratio%20to%20100%20patients%20without%20history%20of%20CRT.%20Thirty-day%20adverse%20events%20were%20analyzed%20with%20generalized%20estimating%20equation%20models.%20Overall%20mortality%20was%20analyzed%20with%20stratified%20Cox%20regression%20modelling.%5CnRESULTS%3A%20Median%20clinical%20follow-up%20was%2024%5Cu00a0months%20%28interquartile%20range%20%5BIQR%5D%2C%2012-44%5Cu00a0months%29.%20There%20was%20no%20difference%20between%20CRT%20and%20non-CRT%20patients%20in%20overall%20mortality%20%28hazard%20ratio%20%5BHR%5D%200.84%20%5B0.37-1.90%5D%2C%20P%5Cu00a0%3D%5Cu00a00.67%29%2C%2030-day%20mortality%20%28HR%203.1%20%5B0.49-20.03%5D%2C%20P%5Cu00a0%3D%5Cu00a00.23%29%2C%20or%2030-day%20readmission%20rate%20%28HR%201.0%20%5B0.43-2.31%5D%2C%20P%5Cu00a0%3D%5Cu00a01%29.%20There%20were%20no%20differences%20in%20the%20rates%20of%20most%20adverse%20events%2C%20but%20patients%20with%20CRT%20history%20had%20higher%20rates%20of%20postprocedural%20respiratory%20failure%20%28HR%203.63%20%5B1.32-10.02%5D%2C%20P%5Cu00a0%3D%5Cu00a00.01%29%20and%20permanent%20pacemaker%20implantation%20%28HR%202.84%20%5B1.15-7.01%5D%2C%20P%5Cu00a0%3D%5Cu00a00.02%29.%5CnCONCLUSIONS%3A%20For%20patients%20with%20aortic%20valve%20stenosis%20and%20previous%20CRT%2C%20TAVR%20is%20safe%20and%20effective%2C%20with%20outcomes%20similar%20to%20those%20in%20the%20general%20aortic%20stenosis%20population.%20Patients%20with%20history%20of%20CRT%20are%20more%20likely%20to%20have%20postprocedural%20respiratory%20failure%20and%20to%20require%20permanent%20pacemaker%20implantation.%22%2C%22date%22%3A%22Apr%2015%2C%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ijcard.2020.12.054%22%2C%22ISSN%22%3A%221874-1754%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22DV9ZHE2J%22%2C%223WHLRQCH%22%2C%22SQD2CTYV%22%2C%22BJSZ96GT%22%2C%22YRK99JHR%22%2C%22Z2XX7DHR%22%2C%22M32R8FP2%22%2C%22AAQ89W3S%22%2C%22X6Y3USZ6%22%2C%22YQ6XGPLC%22%2C%22RB8ZRZCJ%22%2C%222K4N54U2%22%2C%22MZXU6P62%22%2C%228PULYTSK%22%2C%22MDTREPAF%22%5D%2C%22dateModified%22%3A%222022-11-04T15%3A27%3A39Z%22%7D%7D%2C%7B%22key%22%3A%22EXBMDANA%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bailey%20et%20al.%22%2C%22parsedDate%22%3A%222021-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBailey%2C%20A.%20L.%2C%20Dmytrenko%2C%20O.%2C%20Greenberg%2C%20L.%20et%20al.%20%282021%29.%20SARS-CoV-2%20infects%20human%20engineered%26%23xA0%3Bheart%20tissues%20and%20models%20COVID-19%20myocarditis.%20%26lt%3Bi%26gt%3BJACC%20Basic%20Transl%20Sci%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B6%26lt%3B%5C%2Fi%26gt%3B%2C%20331%26%23x2013%3B345.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jacbts.2021.01.002%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jacbts.2021.01.002%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22SARS-CoV-2%20infects%20human%20engineered%5Cu00a0heart%20tissues%20and%20models%20COVID-19%20myocarditis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20L.%22%2C%22lastName%22%3A%22Bailey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Oleksandr%22%2C%22lastName%22%3A%22Dmytrenko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lina%22%2C%22lastName%22%3A%22Greenberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrea%20L.%22%2C%22lastName%22%3A%22Bredemeyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pan%22%2C%22lastName%22%3A%22Ma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jing%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vinay%22%2C%22lastName%22%3A%22Penna%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emma%20S.%22%2C%22lastName%22%3A%22Winkler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sanja%22%2C%22lastName%22%3A%22Sviben%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erin%22%2C%22lastName%22%3A%22Brooks%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajith%20P.%22%2C%22lastName%22%3A%22Nair%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kent%20A.%22%2C%22lastName%22%3A%22Heck%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aniket%20S.%22%2C%22lastName%22%3A%22Rali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leo%22%2C%22lastName%22%3A%22Simpson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mehrdad%22%2C%22lastName%22%3A%22Saririan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dan%22%2C%22lastName%22%3A%22Hobohm%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%20Tom%22%2C%22lastName%22%3A%22Stump%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20A.%22%2C%22lastName%22%3A%22Fitzpatrick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xuping%22%2C%22lastName%22%3A%22Xie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xianwen%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pei-Yong%22%2C%22lastName%22%3A%22Shi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20Travis%22%2C%22lastName%22%3A%22Hinson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Weng-Tein%22%2C%22lastName%22%3A%22Gi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Constanze%22%2C%22lastName%22%3A%22Schmidt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florian%22%2C%22lastName%22%3A%22Leuschner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chieh-Yu%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20S.%22%2C%22lastName%22%3A%22Diamond%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20J.%22%2C%22lastName%22%3A%22Greenberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kory%20J.%22%2C%22lastName%22%3A%22Lavine%22%7D%5D%2C%22abstractNote%22%3A%22There%20is%20ongoing%20debate%20as%20to%20whether%20cardiac%20complications%20of%20coronavirus%20disease-2019%20%28COVID-19%29%20result%20from%20myocardial%20viral%20infection%20or%20are%20secondary%20to%20systemic%20inflammation%20and%5C%2For%20thrombosis.%20We%20provide%20evidence%20that%20cardiomyocytes%20are%20infected%20in%20patients%20with%20COVID-19%20myocarditis%20and%20are%20susceptible%20to%20severe%20acute%20respiratory%20syndrome%20coronavirus%202.%20We%20establish%20an%20engineered%20heart%20tissue%20model%20of%20COVID-19%20myocardial%20pathology%2C%20define%20mechanisms%20of%20viral%20pathogenesis%2C%20and%20demonstrate%20that%20cardiomyocyte%20severe%20acute%20respiratory%20syndrome%20coronavirus%202%20infection%20results%20in%20contractile%20deficits%2C%20cytokine%20production%2C%20sarcomere%20disassembly%2C%20and%20cell%20death.%20These%20findings%20implicate%20direct%20infection%20of%20cardiomyocytes%20in%20the%20pathogenesis%20of%20COVID-19%20myocardial%20pathology%20and%20provides%20a%20model%20system%20to%20study%20this%20emerging%20disease.%22%2C%22date%22%3A%22Apr%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jacbts.2021.01.002%22%2C%22ISSN%22%3A%222452-302X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22AAQ89W3S%22%2C%22S7WF6DG3%22%5D%2C%22dateModified%22%3A%222021-05-06T18%3A43%3A40Z%22%7D%7D%2C%7B%22key%22%3A%223IBSAC2U%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Maffei%20et%20al.%22%2C%22parsedDate%22%3A%222020-06%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMaffei%2C%20S.%20R.%2C%20Lamba%2C%20H.%20K.%2C%20Mensah%2C%20C.%20K.%20et%20al.%20%282020%29.%20Plasmapheresis%20in%20patients%20with%20heparin-induced%20thrombocytopenia%20requiring%20ventricular%20assist%20device.%20%26lt%3Bi%26gt%3BAnn%20Thorac%20Surg%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B109%26lt%3B%5C%2Fi%26gt%3B%2C%20e439%26%23x2013%3Be440.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.athoracsur.2019.09.056%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.athoracsur.2019.09.056%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Plasmapheresis%20in%20patients%20with%20heparin-induced%20thrombocytopenia%20requiring%20ventricular%20assist%20device%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salvador%20R.%22%2C%22lastName%22%3A%22Maffei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harveen%20K.%22%2C%22lastName%22%3A%22Lamba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cassius%20Kwasi%22%2C%22lastName%22%3A%22Mensah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arthur%22%2C%22lastName%22%3A%22Bracey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Civitello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reynolds%22%2C%22lastName%22%3A%22Delgado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leo%22%2C%22lastName%22%3A%22Simpson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajith%22%2C%22lastName%22%3A%22Nair%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.%20H.%22%2C%22lastName%22%3A%22Frazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20A.%22%2C%22lastName%22%3A%22Morgan%22%7D%5D%2C%22abstractNote%22%3A%22Anticoagulation%20with%20unfractionated%20heparin%20is%20vital%20to%20reduce%20the%20risk%20of%20thromboembolic%20events%20during%20cardiopulmonary%20bypass%20and%20left%20ventricular%20assist%20device%20placement.%20However%20patients%20with%20heparin-induced%20thrombocytopenia%20are%20at%20risk%20of%20developing%20immune-mediated%20thrombotic%20events.%20We%20describe%202%20patients%20with%20heparin-induced%20thrombocytopenia%20confirmed%20via%20serotonin%20release%20assay%20who%20were%20successfully%20treated%20with%20plasmapheresis%20exchange%20before%20left%20ventricular%20assist%20device%20placement.%22%2C%22date%22%3A%22Jun%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.athoracsur.2019.09.056%22%2C%22ISSN%22%3A%221552-6259%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22SE7HDD49%22%2C%22KIXH6H5E%22%2C%229FBUJBMU%22%2C%22TIPQ3BD5%22%2C%22AAQ89W3S%22%2C%22S7WF6DG3%22%5D%2C%22dateModified%22%3A%222022-01-25T15%3A05%3A29Z%22%7D%7D%2C%7B%22key%22%3A%223NMRKCAT%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Yang%20et%20al.%22%2C%22parsedDate%22%3A%222020-03%22%2C%22numChildren%22%3A8%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BYang%2C%20Y.%2C%20Rali%2C%20A.%20S.%2C%20Inchaustegui%2C%20C.%20et%20al.%20%282020%29.%20Extracorporeal%20membrane%20oxygenation%20in%20coronavirus%20disease%202019-associated%20acute%20respiratory%20distress%20syndrome%3A%20An%20initial%20US%20experience%20at%20a%20high-volume%20centre.%20%26lt%3Bi%26gt%3BCard%20Fail%20Rev%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B6%26lt%3B%5C%2Fi%26gt%3B%2C%20e17.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.15420%5C%2Fcfr.2020.16%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.15420%5C%2Fcfr.2020.16%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Extracorporeal%20membrane%20oxygenation%20in%20coronavirus%20disease%202019-associated%20acute%20respiratory%20distress%20syndrome%3A%20An%20initial%20US%20experience%20at%20a%20high-volume%20centre%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yang%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aniket%20S.%22%2C%22lastName%22%3A%22Rali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Inchaustegui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Javid%22%2C%22lastName%22%3A%22Alakbarli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Subhasis%22%2C%22lastName%22%3A%22Chatterjee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20P.%22%2C%22lastName%22%3A%22Herlihy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joggy%22%2C%22lastName%22%3A%22George%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexis%22%2C%22lastName%22%3A%22Shafii%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajith%22%2C%22lastName%22%3A%22Nair%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leo%22%2C%22lastName%22%3A%22Simpson%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Mar%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.15420%5C%2Fcfr.2020.16%22%2C%22ISSN%22%3A%222057-7540%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22AAQ89W3S%22%2C%22WS63FIXU%22%2C%22V9VNRSPC%22%2C%22ZMAN8MMI%22%2C%22VCK5HVUS%22%2C%22X2D36SJL%22%5D%2C%22dateModified%22%3A%222022-02-17T16%3A19%3A45Z%22%7D%7D%5D%7D
Gao, F., Kherallah, R., Koetting, M. et al. (2023). Leadless pacemaker with transcatheter aortic valve implantation: A single-center experience. Pacing Clin Electrophysiol. https://doi.org/10.1111/pace.14702.
Akkanti, B., Suarez, E. E., O’Neil, E. R. et al. (2022). Extracorporeal membrane oxygenation for COVID-19: Collaborative experience from the Texas Medical Center in Houston with 2 years follow-up. ASAIO J. https://doi.org/10.1097/MAT.0000000000001791.
Patel, V., Gray, Z., Alam, M. et al. (2022). Peripheral extracorporeal membrane oxygenation support expands the application of robot-assisted coronary artery bypass. JTCVS Tech 13, 92–100. https://doi.org/10.1016/j.xjtc.2022.02.034.
Shah, S. J., Borlaug, B. A., Chung, E. S. et al. (2022). Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial. Lancet, S0140-6736(22)00016–2. https://doi.org/10.1016/S0140-6736(22)00016-2.
Lamba, H. K., Musfee, F. I., Chatterjee, S. et al. (2021). The influence of preoperative dialysis on survival after continuous-flow left ventricular assist device implantation. Interact Cardiovasc Thorac Surg, ivab357. https://doi.org/10.1093/icvts/ivab357.
Chen, Q., Pollet, M., Mehta, A. et al. (2021). Delayed removal of a percutaneous left ventricular assist device for patients undergoing catheter ablation of ventricular tachycardia is associated with increased 90-day mortality. J Interv Card Electrophysiol 62, 49–56. https://doi.org/10.1007/s10840-020-00875-y.
Kherallah, R. Y., Harrison, D., Preventza, O. et al. (2021). Transcatheter aortic valve replacement after chest radiation: A propensity-matched analysis. Int J Cardiol 329, 50–55. https://doi.org/10.1016/j.ijcard.2020.12.054.
Bailey, A. L., Dmytrenko, O., Greenberg, L. et al. (2021). SARS-CoV-2 infects human engineered heart tissues and models COVID-19 myocarditis. JACC Basic Transl Sci 6, 331–345. https://doi.org/10.1016/j.jacbts.2021.01.002.
Maffei, S. R., Lamba, H. K., Mensah, C. K. et al. (2020). Plasmapheresis in patients with heparin-induced thrombocytopenia requiring ventricular assist device. Ann Thorac Surg 109, e439–e440. https://doi.org/10.1016/j.athoracsur.2019.09.056.
Yang, Y., Rali, A. S., Inchaustegui, C. et al. (2020). Extracorporeal membrane oxygenation in coronavirus disease 2019-associated acute respiratory distress syndrome: An initial US experience at a high-volume centre. Card Fail Rev 6, e17. https://doi.org/10.15420/cfr.2020.16.